BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes in Southeast Asia. Cytivas BioChallenge aims to support the innovation of biotec
/PRNewswire/ Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva.
VivaZome Therapeutics wins top prize with its potential to provide off-the-shelf regenerative medicines. Part of Cytiva's BioChallenge global series, the inaugural challenge for the Australia and New Zealand region received 32 applications from various universities and companies. SYDNEY, Feb. 1, 2022 /PRNewswire/ Cytiva, a global life sciences leader, announces the winner of its first BioChallenge for the.
01 febbraio 2021 06:48
Fonte: Adnkronos
#salute-e-benessere
- Cytiva will now provide idea to injection solutions to customers and the market
- Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies
- First acquisition by company since becoming Cytiva in April 2020
AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire/ Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
This is the first acquisition by Cytiva. Emmanuel Ligner, President and CEO, Cytiva, says: Since becoming a Danaher operating company in April 2020, we have already begun fueling innovation and re-investing in the business for the benefit of our customers and their patients. We are thrilled to welcome the Vanrx associates to our family and look forward to working together on delivering meaningful solutio